Pediatrix Medical Group Inc (MD) Stock Price, Quote & News

Company Profile

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-ba...

Industry: Medical Care Facilities

Sector: Healthcare

Phone: 954 384 0175

Website: www.pediatrix.com

Address:

1301 Concord Terrace, Sunrise, United States

wisdom_trade Aug. 29 at 6:46 PM

$IOT $NVDA $MD AVGO new generation AI stocks

0 · Reply

ZacksResearch Aug. 19 at 5:12 PM

$MD's shareholder-friendly moves: Is it time to buy? 📈 Pediatrix Medical has expanded its share repurchase authorization to $250M, leveraging strong cash flow and solidifying value for investors. With a 21.9% YTD gain, a low forward P/E of 9.54x, and a Zacks Rank #1, the setup looks promising. Discover why MD could be a strong addition to your portfolio 👉 https://www.zacks.com/stock/news/2735167/pediatrix-medical-refills-its-buyback-prescription-with-250m-dose?cid=sm-stocktwits-2-2735167-body-8425&ADID=SYND_STOCKTWITS_TWEET_2_2735167_BODY_8425

0 · Reply

ZacksResearch Aug. 19 at 4:12 PM

$MD just prescribed itself a $250M buyback 💊 Backed by stronger cash flow, leaner operations, and a robust 2025 profit outlook, management is doubling down on shareholder returns. See the full breakdown here 👉 https://www.zacks.com/stock/news/2735167/pediatrix-medical-refills-its-buyback-prescription-with-250m-dose?cid=sm-stocktwits-2-2735167-teaser-8424&ADID=SYND_STOCKTWITS_TWEET_2_2735167_TEASER_8424

0 · Reply

ZacksResearch Aug. 8 at 7:16 PM

$MD soars 12.1% post-Q2 earnings — what's driving the rally? 🚀 Pediatrix crushed EPS estimates by 26.2%. Quarterly results were aided by higher patient volumes, improved patient acuity, and slashed operating expenses. However, net revenues dipped 7% due to practice dispositions. 📉 Discover the full breakdown here 👉 https://www.zacks.com/stock/news/2685263/pediatrix-medicals-q2-earnings-beat-on-strong-patient-volumes?cid=sm-stocktwits-2-2685263-body-7023&ADID=SYND_STOCKTWITS_TWEET_2_2685263_BODY_7023

0 · Reply

Estimize Aug. 4 at 6:00 PM

$MD reports before the open tomorrow, Estimize Consensus +0.02 EPS and +1.78M Revs compared to WS http://www.estimize.com/md/fq2-2025?utm_c

0 · Reply

LewisDaKat Jun. 15 at 9:55 PM

News (MD) Technical Data https://marketwirenews.com/news-releases/-md-technical-data-8912284207115659.html $MD

0 · Reply

PitchStack Jun. 6 at 9:31 PM

$MD Our team recently reviewed a new Pediatrix stock pitch from Substack. Pediatrix (NYSE: MD) 🇺🇸 | $ 1.20 B | Healthcare | Turnaround Pediatrix Medical Group, Inc. provides specialised newborn, maternal-fetal, and paediatric cardiology care services in the United States and Puerto Rico. By divesting non-core units, Pediatrix has improved its margins and financial stability. The company benefits from macroeconomic tailwinds, such as increased demand for neonatal and maternal-fetal care due to demographic trends. Additionally, its strong presence in high-growth regions like the Southeast supports sustained growth and margin recovery. Link: https://deepvaluecapitalbykyler.substack.com/p/the-nicu-specialist-built-to-last Our team also analysed 18 other pitches, with the full breakdown available at PitchStack: www.pitchstack-investing.com"

0 · Reply

ZacksResearch May. 28 at 1:58 PM

$MD defies industry trends with a strong YTD gain! 🚀 Pediatrix Medical is up 5.6% YTD, outpacing the industry’s 6.4% decline. Their forward P/E of 8.72 is notably below the industry average, signaling potential value. Discover why MD could be a solid addition to your portfolio 👉 https://www.zacks.com/commentary/2478230/heres-why-you-should-add-pediatrix-medical-to-your-portfolio-now?cid=sm-stocktwits-2-2478230-body&ADID=SYND_STOCKTWITS_TWEET_2_2478230_BODY

0 · Reply

ZacksResearch May. 28 at 12:45 PM

$MD rises 5.6% YTD as earnings beat, hospital deals and lower costs drive growth. The Zacks Rank #2 signals strong near-term prospects. Explore further: https://www.zacks.com/stock/news/2478230/heres-why-you-should-add-pediatrix-medical-to-your-portfolio-now?cid=sm-stocktwits-2-2478230-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2478230_TEASER

0 · Reply

Rodsgo May. 23 at 12:17 PM

$MD

0 · Reply

Pediatrix Medical Group Announces $250 Million Share Repurchase Program

Aug 5, 2025, 10:50 AM EDT - 25 days ago

Pediatrix Medical Group, Inc. (MD) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 6:00 AM EDT - 25 days ago

Pediatrix Medical Group Reports Second Quarter Results

Jul 21, 2025, 7:00 AM EDT - 5 weeks ago

Pediatrix Medical Group 2025 Second Quarter Conference Call/Webcast Scheduled for Tuesday, August 5, 2025

Jul 1, 2025, 4:05 PM EDT - 2 months ago

Pediatrix Board Appoints Kurt D. Newman, M.D.

May 6, 2025, 10:55 AM EDT - 4 months ago

Pediatrix Medical Group, Inc. (MD) Q1 2025 Earnings Call Transcript

May 6, 2025, 6:00 AM EDT - 4 months ago

Pediatrix Medical Group Reports First Quarter Results

Apr 21, 2025, 7:00 AM EDT - 4 months ago

Pediatrix Medical Group 2025 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 6, 2025

Feb 20, 2025, 3:50 PM EST - 6 months ago

Top 3 Health Care Stocks You May Want To Dump In February

LUNG SWTX

Feb 20, 2025, 1:29 PM EST - 6 months ago

Pediatrix Medical Group, Inc. (MD) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 1:06 PM EST - 6 months ago

Pediatrix Q4 Beats Estimates As Operational Improvements Drive Performance

Feb 20, 2025, 6:00 AM EST - 6 months ago

Pediatrix Medical Group Reports Fourth Quarter Results

Feb 11, 2025, 6:00 AM EST - 7 months ago

Pediatrix Medical Group to Host Premier Neonatology Conference Feb. 19-21

Feb 10, 2025, 7:00 AM EST - 7 months ago

Pediatrix Medical Group 2024 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 20, 2025

Jan 13, 2025, 6:00 AM EST - 8 months ago

Pediatrix Announces Strategic Initiatives For Enhanced Shareholder Value Creation

Nov 1, 2024, 11:52 AM EDT - 10 months ago

Pediatrix Medical Group, Inc. (MD) Q3 2024 Earnings Call Transcript

Nov 1, 2024, 6:00 AM EDT - 10 months ago

Pediatrix Medical Group Reports Third Quarter Results

Oct 16, 2024, 6:45 AM EDT - 11 months ago

Pediatrix Medical Group 2024 Third Quarter Conference Call/Webcast Scheduled for Friday, November 1, 2024

Aug 6, 2024, 12:28 PM EDT - 1 year ago

Pediatrix Medical Group, Inc. (MD) Q2 2024 Earnings Call Transcript

Jul 18, 2024, 7:00 AM EDT - 1 year ago

Pediatrix Medical Group 2024 Second Quarter Conference Call/Webcast Scheduled for Tuesday, August 6, 2024

Jun 14, 2024, 4:02 PM EDT - 1 year ago

Federman & Sherwood Announces Preliminary Approval of Settlement in MedNax Services, Inc., Customer Data Security Breach Litigation

May 22, 2024, 6:45 AM EDT - 1 year ago

Pediatrix Medical Group To Present at Upcoming Investor Conferences

May 7, 2024, 11:11 AM EDT - 1 year ago

Pediatrix Medical Group, Inc. (MD) Q1 2024 Earnings Call Transcript

Apr 22, 2024, 6:45 AM EDT - 1 year ago

Pediatrix Medical Group 2024 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 7, 2024

Feb 20, 2024, 12:47 PM EST - 1 year ago

Pediatrix Medical Group, Inc. (MD) Q4 2023 Earnings Call Transcript

Feb 7, 2024, 6:45 AM EST - 1 year ago

Pediatrix Medical Group 2023 Fourth Quarter Conference Call/Webcast Scheduled for Tuesday, February 20, 2024

Dec 1, 2023, 10:47 AM EST - 1 year ago

Top 5 Health Care Stocks That Could Blast Off In December - DBV Technologies (NASDAQ:DBVT), Cigna Group (NYSE:CI)

CI DBVT PDCO

Nov 16, 2023, 2:20 PM EST - 1 year ago

Miller Children's & Women's Announces New Miller Children's & Women's Neonatal Network in Partnership with Pediatrix Medical Group, Dr. Antoine Soliman Named Regional Medical Director

Nov 5, 2023, 12:34 AM EDT - 1 year ago

Pediatrix Medical Group, Inc. (MD) Q3 2023 Earnings Call Transcript

Oct 20, 2023, 6:45 AM EDT - 2 years ago

Pediatrix Medical Group 2023 Third Quarter Conference Call/Webcast Scheduled for Thursday, November 2, 2023

Aug 6, 2023, 8:49 AM EDT - 2 years ago

Pediatrix Medical Group, Inc. (MD) Q2 2023 Earnings Call Transcript

Jul 18, 2023, 6:45 AM EDT - 2 years ago

Pediatrix Medical Group 2023 Second Quarter Conference Call/Webcast Scheduled for Thursday, August 3, 2023

May 4, 2023, 4:05 PM EDT - 2 years ago

Pediatrix Board Appoints Sylvia Young as Independent Director

May 3, 2023, 6:45 AM EDT - 2 years ago

Pediatrix Medical Group to Present at 2023 Bank of America Health Care Conference

May 2, 2023, 1:11 PM EDT - 2 years ago

Pediatrix Medical Group, Inc. (MD) Q1 2023 Earnings Call Transcript

Apr 26, 2023, 6:45 AM EDT - 2 years ago

Pediatrix Medical Group 2023 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 2, 2023

Mar 8, 2023, 5:36 PM EST - 2 years ago

James D. Swift, M.D., Elected to Pediatrix Board of Directors

Feb 17, 2023, 2:00 PM EST - 2 years ago

Pediatrix Medical Group, Inc. (MD) Q4 2022 Earnings Call Transcript

Feb 6, 2023, 6:45 AM EST - 2 years ago

Pediatrix Medical Group 2022 Fourth Quarter Conference Call/Webcast Scheduled for Friday, February 17, 2023

Dec 15, 2022, 4:41 PM EST - 2 years ago

Pediatrix Announces Leadership Transitions

Dec 1, 2022, 6:50 AM EST - 2 years ago

Pediatrix® Medical Group Releases Inaugural Sustainability Report

Nov 7, 2022, 6:45 AM EST - 3 years ago

Pediatrix Medical Group to Present at Credit Suisse 31st Annual Healthcare Conference

Nov 6, 2022, 9:38 PM EST - 3 years ago

Pediatrix Medical Group, Inc. (MD) Q3 2022 Earnings Call Transcript

Oct 21, 2022, 6:45 AM EDT - 3 years ago

Pediatrix Medical Group 2022 Third Quarter Conference Call/Webcast Scheduled for Thursday, November 3, 2022

Sep 29, 2022, 12:52 PM EDT - 3 years ago

Pediatrix: These 5 Graphs Suggest It's A Buy

Aug 22, 2022, 3:00 PM EDT - 3 years ago

Pediatrix Medical Group Comments on No Surprises Act Final Rule

Aug 7, 2022, 9:50 PM EDT - 3 years ago

Pediatrix Medical Group, Inc. (MD) CEO Mark Ordan on Q2 2022 Results - Earnings Call Transcript

Jul 14, 2022, 12:06 AM EDT - 3 years ago

Pediatrix: Seeking 46% Return Objective As Speculative Buy

Jul 13, 2022, 6:45 AM EDT - 3 years ago

Pediatrix Medical Group 2022 Second Quarter Conference Call/Webcast Scheduled for Thursday, August 4, 2022

Jun 21, 2022, 6:45 AM EDT - 3 years ago

Mednax To Change Name to Pediatrix Medical Group, Inc. Effective July 1, 2022

wisdom_trade Aug. 29 at 6:46 PM

$IOT $NVDA $MD AVGO new generation AI stocks

0 · Reply

ZacksResearch Aug. 19 at 5:12 PM

0 · Reply

ZacksResearch Aug. 19 at 4:12 PM

0 · Reply

ZacksResearch Aug. 8 at 7:16 PM

0 · Reply

Estimize Aug. 4 at 6:00 PM

$MD reports before the open tomorrow, Estimize Consensus +0.02 EPS and +1.78M Revs compared to WS http://www.estimize.com/md/fq2-2025?utm_c

0 · Reply

LewisDaKat Jun. 15 at 9:55 PM

News (MD) Technical Data https://marketwirenews.com/news-releases/-md-technical-data-8912284207115659.html $MD

0 · Reply

PitchStack Jun. 6 at 9:31 PM

0 · Reply

ZacksResearch May. 28 at 1:58 PM

0 · Reply

ZacksResearch May. 28 at 12:45 PM

0 · Reply

Rodsgo May. 23 at 12:17 PM

$MD

0 · Reply

Winning_calls May. 17 at 12:09 AM

$MD 👌🫡🫡

0 · Reply

vjtweet May. 16 at 1:48 AM

$MD playbook here ... if it acts well. No position yet.

0 · Reply

Winning_calls May. 12 at 12:08 PM

$MD 😉🤞🤞

0 · Reply

Winning_calls May. 12 at 2:19 AM

$MD pick me up @ $14.60

0 · Reply

ZacksResearch May. 9 at 2:47 PM

🚀 $MD surges 11.5% post-earnings — is this just the beginning? 📈 Adjusted EPS of 33 cents crushed the Zacks Consensus Estimate by 32% 💰 Same-unit revenue growth of 6.2% outperformed expectations 📉 Total operating expenses dropped 11% year over year Discover why this stock is heating up 👉 https://www.zacks.com/commentary/2466247/pediatrix-medicals-q1-earnings-beat-estimates-on-declining-costs?cid=sm-stocktwits-2-2466247-body&ADID=SYND_STOCKTWITS_TWEET_2_2466247_BODY

0 · Reply

JarvisFlow May. 8 at 1:00 PM

Macquarie has adjusted their stance on Pediatrix Medical Group ( $MD ), setting the rating to Outperform with a target price of 19 → 20.

0 · Reply

Estimize May. 5 at 6:00 PM

$MD reports before the open tomorrow, Estimize Consensus +0.02 EPS and +2.52M Revs compared to WS http://www.estimize.com/md/fq1-2025?utm_c

0 · Reply

ZacksResearch May. 2 at 4:35 PM

Is $MD ready to surprise, or is the momentum fading? 🤔 📉 First-quarter earnings expected at 25 cents, but revenue is projected to drop 8.2% year-over-year to $454.5 million. 📊 The company's earnings ESP stands at 0.00% with a Zacks Rank #2, indicating uncertainty around a potential beat. 🔍 Same-facility revenue growth is only pegged at 0.75%, raising some red flags. Find out what this means for the stock 👉 https://www.zacks.com/commentary/2461294/can-lower-expenses-save-pediatrix-medicals-q1-earnings?cid=sm-stocktwits-2-2461294-body&ADID=SYND_STOCKTWITS_TWEET_2_2461294_BODY

0 · Reply

Dreamer89 Apr. 11 at 9:38 PM

$IOTR $CUPR $MD booooooom Mb dumped. Winnerrrrrrr. Iotr and cupr will do the same. 🤣🤣🤣

0 · Reply

Dreamer89 Apr. 11 at 9:34 PM

$IOTR $CUPR $MD lol china garbage ipo pumped after hour cuz trump market wont let it run intra day. These will get absolutely killed on monday 🤣🤣🤣🤣🤣

0 · Reply

JarvisFlow Apr. 11 at 1:00 PM

Truist Securities has updated their rating for Pediatrix Medical Group ( $MD ) to Hold with a price target of 16.

0 · Reply

Omegacy2 Apr. 4 at 5:28 PM

$SPY 510 -5% $QQQ 427 -5.2% i predicted next week market recover +3-5% bc we are friday market are weaker. in 2 weeks cpi and pre er rally i pt +5-10% as previous ers called since oct 2022. 80-90% winners. Omegacy2 Aug 05, 2024 9:33 AM $QQQ 427 -5% $SPY 513 -3.7% Will Bounce back 2-3%+ Today Omegacy2 Aug 07, 2024 5:11 PM $SPY 516 $QQQ 432 $NVDA 97.5. I Called Big Bounce Many Times Omegacy2 Jul 30, 2024 1:24 PM $MD 136. ER amc. it Price in. AMD will Rally 150-160+ to $NVDA 104.5 ER. I PT 125-130+ Omegacy2 Jul 31, 2024 6:34 PM "But Market $QQQ $SPY Will start to Drop Since Morning Pop to Friday OPEX" Omegacy2 Oct 13, 2022 10:09 AM $SPY is now 350 $SPY 410+ in 5 weeks for ER

1 · Reply

Market Cap	1.50B
Revenue (ttm)	2.01B
Net Income (ttm)	-99.07M
EPS (ttm)	N/A
PE Ratio	9.99
Forward PE	10.24
Profit Margin	-4.92%
Debt to Equity Ratio	0.73

Volume	710,100
Avg Vol	751,936
Day's Range	N/A - N/A
Shares Out	87.08M
Stochastic %K	94%
Beta	1.21
Analysts	Sell
Price Target	$16.71